Evidence map›Paper›PMID 35275330›Full record

ArticleIn vitro cellular & developmental biology. Animal2022

BMP2 increases hyperplasia and hypertrophy of bovine subcutaneous preadipocytes via BMP/SMAD signaling.

Liang Yang, Weiguang Hao, Hongzhuang Wang, Wanping Ren, Peishi Yan, Shengjuan Wei

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Functional Variant Alters the Binding ofAnimals : an open access journal from MDPI · 2023
    Article
  6. The Effects ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Liang YangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.
Weiguang HaoCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.
Hongzhuang WangCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.
Wanping RenCollege of Animal Science, Xinjiang Agricultural University, Urumchi, 830052, China.
Peishi YanCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.
Shengjuan WeiCollege of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China. sjwei@njau.edu.cn.ORCID http://orcid.org/0000-0001-7340-8208
Nanjing Agricultural University · CNXinjiang Agricultural University · CN

Funding

Fundamental Research Funds for the Central Universities KYYJ202102Jiangsu Agricultural Science and Technology Innovation Fund CX(21)3136National Natural Science Foundation of China 31501930
6 · The paper itself

Abstract

The study aims to characterize functions of bone morphogenetic protein 2 (BMP2) gene in the process of subcutaneous (SQ) fat deposition of bovine, thereby providing insights into mechanisms for the use of BMP2 in fat management. Our results show that BMP2 was extensively expressed in bovine and relatively rich in adipose tissue. Exogenous BMP2 significantly enhanced proliferation of bovine preadipocytes. Consistently, si-BMP2 apparently induced cell cycle arrest at G0/G1 phase and decreased proliferation of preadipocytes. Meanwhile, exogenous BMP2 mildly enhanced preadipocyte differentiation at day 3 of differentiation, as evidenced by accelerated lipid accumulation, as well as increased mRNA and protein expressions of adipogenic key transcription factor PPARγ; contrary results about lipids were found by BMP2 interference treatment. No difference was observed concerning BMP2 or si-BMP2 treatment at day - 2 and day 0 of differentiation. Additionally, LDN-193189 (inhibitor of BMP type I receptor) pretreatment diminished the enhancement of preadipocyte proliferation and differentiation induced by BMP2, as evidenced by constant proliferation rate and PPARγ expressions. Furthermore, BMP2 markedly enhanced phosphorylation level of SMAD1/5/9, and LDN-193189 could diminish the difference caused by BMP2. Thus, our results suggest that BMP2 triggers BMP/SMAD signaling pathway, promoting both hyperplasia and hypertrophy of bovine preadipocytes.

Indexed as

Bone Morphogenetic Protein 2Cattle DiseasesAnimalsCattleCell DifferentiationCells, CulturedHyperplasiaHypertrophyPPAR gammaSignal TransductionSmad ProteinsBone Morphogenetic Protein 2PPAR gammaSmad ProteinsBMP2BovineDifferentiationPreadipocyteProliferation

Identifiers

PMID35275330
OpenAlexW4220764192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.